First up is Team Immunity, an Oceanic organization that is now barred from participating in any Riot-sponsored competitions because its manager didn’t pay the players “in a timely fashion.” The players themselves aren’t banned but will have to reform as a new team to partake in upcoming championships. They claim “a mistake has been made” and are allegedly contesting the ban with Riot.
Then there’s Team Odyssey, which is coming under fire because its owner is reportedly price-gouging customers in his private, non-gaming business. Turing Pharmaceuticals CEO and Team Odyssey owner Martin Shkreli acquired the rights to sell Daraprim, a drug used, among other things, to treat malaria. He jacked up the price 5,500%, raising the ire of patients worldwide and prompting calls for Riot to investigate whether or not Shkreli violated the “moral turpitude” clause of the studio’s e-sports rules. Shkreli has since announced that he would be lowering the price on the drug.